PROVIDER PROFILE · NPI 1972763340

Nicole HarrellM.D.

DermatologyBaton Rouge, LAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,445

Unique beneficiaries

—

Total services

12,493

Distinct HCPCS

Medicare payment

$113K

Peer benchmark

Total Medicare services vs. 184 Dermatology providers in LA — top quintile (cohort median 2,317).

PRESCRIBING · PART D · 2024

Total Rx claims

1,159

Beneficiaries

—

Total drug cost

$755K

Distinct drugs

Brand share

13.5%

Top prescribed drugs

Triamcinolone Acetonide206 claims

Hydrocortisone106 claims

Ketoconazole95 claims

Clobetasol Propionate81 claims

Dupilumab75 claims

QUALITY · MIPS · 2024

Final MIPS score

91.5

Quality

84.5

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.69%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Education$100

REFERRAL NETWORK

Where Nicole Harrell's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Ashley Allison Pathology · Homewood, AL	92	256
OUR LADY OF THE LAKE HOSPITAL INC.	63	203
EAST BATON ROUGE MEDICAL CENTER LLC	26	54
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	21	34
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	15	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history